Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_assertion type Assertion NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_head.
- NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_assertion description "[These data provide new insights into TRAIL-induced necroptosis with PARP-1 being active effector downstream of RIPK1/RIPK3 initiators and suggest that pharmacological inhibitors of RIPKs and PARP-1 could be new treatment options for immune-mediated hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_provenance.
- NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_assertion evidence source_evidence_literature NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_provenance.
- NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_assertion SIO_000772 22814620 NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_provenance.
- NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_assertion wasDerivedFrom befree-20150227 NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_provenance.
- NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_assertion wasGeneratedBy ECO_0000203 NP803309.RAshLPn6ROAIXIdgpk2cZ_pwx3qW5kiZpiwVJRllDpomY130_provenance.